BCPC Stock Analysis: Buy, Sell, or Hold?
BCPC - Balchem Corporation
$23.70
-142.69 (-85.76%)
▼
5d:
+0.85%
30d:
-4.91%
90d:
-85.02%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Apr 23, 2026
23d
Get Alerted When BCPC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BCPC trading at deep discount. Market pricing in -35.3% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: BCPC trading at deep discount. Market pricing in -35.3% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$113.75
Based on 5.4% avg growth
INTRINSIC VALUE TODAY
$70.63
66.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BCPC is currently trading at $23.70, which is considered slightly low relative to its 30-day fair value range of $16.52 to $165.95. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.9) compared to its historical average (14.4). Remarkably, the market is currently pricing in an annual earnings decline of 35.3% over the next few years. This pessimistic expectation contrasts with the company's recent 17.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BCPC is in a downtrend. The price is currently testing key support at $23.37. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 85.8% recently.
Market Sentiment: BCPC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $200.50 (+746.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BCPC is in a downtrend. The price is currently testing key support at $23.37. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 85.8% recently.
Market Sentiment: BCPC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $200.50 (+746.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$16.52 -
$165.95
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
85.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-85.8%)
- BULLISH: Trading 746.0% below Wall St target ($200.50)
Fair Price Analysis
30-Day Fair Range
$16.52 -
$165.95
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$23.37
Resistance Level
$170.00
Current Trend
Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.90
Wall Street Target
$200.50
(+746.0%)
Revenue Growth (YoY)
9.8%
Earnings Growth (YoY)
17.3%
Profit Margin
14.9%
Valuation Discount vs History
-35.3% cheaper
PE vs Historical
3.9 vs 14.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-35.3%
(market-implied from PE analysis)
1-Year Target
$21.33
(-10%)
2-Year Target
$19.20
(-19%)
3-Year Target
$17.28
(-27%)
3-Yr Target (if PE normalizes)
(PE: 4→14)
$63.76
(+169%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 6.8%)
$165.88
(+600%)
Base:
(SPY PE: 3.9, Growth: 6.8%)
$28.89
(+22%)
Bear:
(PE: 3.3, Growth: 6.8%)
$24.56
(+4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (4x PE) as earnings recover.
Trailing PE: 34.11 | Current EPS (TTM): $4.75
Bull Case
$227.89
(+39%)
Analyst growth 27.9%, PE expands to 37.5
Base Case
$207.17
(+26%)
Market implied 27.9%, PE stable at 34.1
Bear Case
$110.17
(-33%)
Severe decline -20.0%, PE contracts to 29.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.9 to 14.4
Stabilization Target:
$87.47
(+269.1%)
PE Expansion Potential:
+269.1%
Share & Embed Analysis
Last updated: March 30, 2026 8:25 AM ET
Data refreshes hourly during market hours. Next update: 9:25 AM
Data refreshes hourly during market hours. Next update: 9:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCPC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Gunsteren Job Leonard Van
SELL
6000 shares
2025-12-04
David B Fischer
SELL
8000 shares
2025-12-03
Top Rated Specialty Chemicals Stocks
Top-rated stocks in Specialty Chemicals by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LIN
Linde plc Ordinary Shares |
BUY
28 analysts |
$516 | 60 HOLD |
|
SHW
Sherwin-Williams Co |
BUY
28 analysts |
$388 | 62 BUY |
|
IFF
International Flavors & … |
STRONG BUY
22 analysts |
$91 | 63 BUY |
|
APD
Air Products and Chemica… |
BUY
24 analysts |
$308 | 63 BUY |
|
DD
Dupont De Nemours Inc |
STRONG BUY
20 analysts |
$53 | 60 BUY |
